Stockreport

BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets

BioAtla, Inc.  (BCAB) 
PDF SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development o [Read more]